Molecular genetic and cytogenetic determinants of primary resistance or loss of the response to treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukemia

Journal Title: Медичні перспективи - Year 2015, Vol 20, Issue 3

Abstract

Aim of this study was to analyze molecular genetic and cytogenetic reasons for disease resistance to tyrosine kinase inhibitors (TKI) imatinib (IM) and nilotinib (NI) in patients with chronic myeloid leukemia (CML). Material and methods. A group of 32 CML patients with primary or acquired resistance to TKI treatment was investigated. Cytogenetic response was determined by conventional karyotyping with differential banding. Presence of BCR-ABL kinase domain mutations was investigated by direct sequencing. Results and discussion. The frequency of mutations was 37% (12 patients) with prevailing occurrence of mutations with low sensitivity to nilotinib – E255K/V; Т315I; F359V; Y253H. In 47% of the cases (15 patients) additional chromosome aberrations (ACA) were revealed which could also be the reason for TKI resistance in patients without BCR/ABL mutations. Patients with detected mutations of BCR/ABL gene were either switched to nilotinib or treated with increased dose of IM. Cytogenetic response was achieved in only 2 patients with mutations and in 12 patients without them. Frequency of blast crisis development did not differ significantly in both groups. Conclusions. Among the investigated patients with CML resistant to IM BCR/ABL gene mutations were detected in more than third of the cases whereas ACA were found in almost half of the group. Taking into account revealed prevalence of mutations not sensitive to the 2nd generation TKI nilotinib, investigation of mutational status has to be obligatory in all patients for whom treatment correction is considered. Presence of ACA should also be taken into account in patients requiring administration of the second line TKI since they can adversely influence expected treatment response as well.

Authors and Affiliations

K. Kotlyarchuk, Z. Maslyak, A. Lukianova, O. Tsyapka , I. Selina, H. Usenko

Keywords

Related Articles

The use of low-invasive surgical procedures in the treatment of gunshot wounds of the liver

The problem of diagnostics and stage surgical treatment of a combat trauma of the abdomen with liver damage is actual in conditions of increasing specific gravity of liver damage, accompanied by its severe functional ins...

Особливості перебігу інфакту міокарда в пацієнтів з постійною формою фібриляції передсердь

Особенности течения инфаркта миокарда у пациентов с постоянной формой фибрилляции предсердий. Яловенко М.И, Ханюков А.А. Фибрилляция предсердий (ФП) представляет собой наиболее рас­пространенное нарушение ритма сердца в...

Клинический случай синкопе кардиогенного генеза у подростка

Клінічний випадок кардіогенного синкопе в підлітка. Гайдук О.І., Іванусь С.Г., Гайдук Т.А., Швирид І.І., Крамаренко Л.М., Баралей Т.В. У статті наведено клінічний випадок кардіогенного синкопе в дівчинки 15-річного віку...

Management of patients with pulmonary arterial hypertension against of systemic sclerodermia (part 1)

Pulmonary arterial hypertension (PAH) is a serious condition caused by the damage to the small pulmonary vessels, leading to the increase of pulmonary artery pressure, pulmonary vascular resistance, development of right...

 Гігієнічна оцінка стану водних об’єктів у місцях водокористування населення Українського Придунав’я

 Данные литературы и результаты монито¬ринга воды водных объектов Украинского Придунавья по санитарно-микробиологическим, физико-химическим и санитарно-химическим показателям свидетельствуют о неблагоприятных измен...

Download PDF file
  • EP ID EP90057
  • DOI -
  • Views 111
  • Downloads 0

How To Cite

K. Kotlyarchuk, Z. Maslyak, A. Lukianova, O. Tsyapka, I. Selina, H. Usenko (2015). Molecular genetic and cytogenetic determinants of primary resistance or loss of the response to treatment with tyrosine kinase inhibitors in patients with chronic myeloid leukemia. Медичні перспективи, 20(3), 67-73. https://europub.co.uk./articles/-A-90057